Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Culture, Organoids & Tox Screening Europe 2019

Paul Vulto's Biography



Paul Vulto, Managing Director, MIMETAS

Paul Vulto is CEO and co-founder of MIMETAS. Under his guidance, MIMETAS developed into a multinational company with operations in Europe, US and Japan. MIMETAS currently works with the majority of top-50 pharma companies and counts over 85 co-workers. Paul is the inventor behind the OrganoPlate® platform and PhaseGuide technology of MIMETAS. Prior to founding MIMETAS, Paul worked for the high-tech company Silicon Biosystems in Bologna, the Institute for Microsystems Engineering (IMTEK) at the University of Freiburg and the Leiden Academic Centre for Drug Research, Leiden University. Paul holds a cum Laude masters degree in Electrical Engineering and a cum Laude PhD degree in Microsystems Engineering.

Paul Vulto Image

Emerging Themes in Organoids and Organs-on-Chips: An Introduction

Thursday, 13 June 2019 at 13:50

Add to Calendar ▼2019-06-13 14:30:002019-06-13 15:30:00Europe/LondonMerging Organ-on-a-Chip with Organoids: The Best of Two Worlds?3D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Merging Organ-on-a-Chip with Organoids: The Best of Two Worlds?

Thursday, 13 June 2019 at 14:30

Add to Calendar ▼2019-06-13 14:30:002019-06-13 15:30:00Europe/LondonMerging Organ-on-a-Chip with Organoids: The Best of Two Worlds?3D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Organ-on-a-Chip and organoids are two fields of development that are rapidly redefining  cell culture biology in the 21st century. Organ-on-a-Chip technology has demonstrated how microengineering technology can add aspects such as perfusion flow, patterning of tissues, precise control over gradients and application of mechanical strain to tissue culture. Organoid protocols have been carefully optimized to maintain the stem cell niche in developing and adult tissues, while at the same time permitting cell proliferation and differentiation.

In this lecture, I will show latest progress at MIMETAS integrating organoid protocols and Organ-on-a-Chip technology. I will show a range of tissue models comprising complex co-cultures, in a perfused system using state of the art stem cell and organoid protocols. Following this presentation, it will become clear that the two fields are merging together to aid cell culture of the 21st century.


Add to Calendar ▼2019-06-13 00:00:002019-06-14 00:00:00Europe/London3D-Culture, Organoids and Tox Screening Europe 20193D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com